1. Home
  2. Analysis
  3. Carboplatin
  4. Device-occlusion

Carboplatin and Device occlusion - a phase IV clinical study of FDA data

Summary:

Device occlusion is reported as a side effect among people who take Carboplatin (carboplatin), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Neulasta, and have Small cell lung cancer extensive stage.

The phase IV clinical study analyzes which people have Device occlusion when taking Carboplatin. It is created by eHealthMe based on reports of 127,949 people who have side effects when taking Carboplatin from the FDA, and is updated regularly.

What is Carboplatin?

Carboplatin has active ingredients of carboplatin. It is often used in cancer. eHealthMe is studying from 128,210 Carboplatin users. Check the latest studies of Carboplatin.

What is Device occlusion?

Device occlusion is found to be associated with 592 drugs and 514 conditions by eHealthMe. Check the latest studies of Device occlusion.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 30, 2026

127,949 people reported to have side effects when taking Carboplatin.
Among them, 47 people (0.04%) have Device occlusion.

Could Carboplatin cause Device occlusion?

Among these 47 people:

How long have people been on Carboplatin when they have Device occlusion? *

  • < 1 month: 50 %
  • 1 - 6 months: 50 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

What is the gender of people who have Device occlusion when taking Carboplatin? *

  • female: 68.09 %
  • male: 31.91 %

What is the age of people who have Device occlusion when taking Carboplatin? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 15.22 %
  • 30-39: 2.17 %
  • 40-49: 17.39 %
  • 50-59: 30.43 %
  • 60+: 34.78 %

What are other drugs people take besides Carboplatin? *

  1. Neulasta: 22 people, 46.81%
  2. Paclitaxel: 16 people, 34.04%
  3. Cimetidine: 14 people, 29.79%
  4. Taxotere: 10 people, 21.28%
  5. Herceptin: 9 people, 19.15%
  6. Acetaminophen: 8 people, 17.02%
  7. Dexamethasone: 8 people, 17.02%
  8. Etoposide: 7 people, 14.89%
  9. Hexadrol: 7 people, 14.89%
  10. Hydrochlorothiazide: 7 people, 14.89%

What are other side effects people have besides Device occlusion? *

  1. Thrombocytopenia (decrease of platelets in blood): 20 people, 42.55%
  2. Dyspnea (difficult or laboured breathing): 16 people, 34.04%
  3. Fever: 15 people, 31.91%
  4. Night Sweats (sweating in night): 15 people, 31.91%
  5. Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 14 people, 29.79%
  6. Pain: 14 people, 29.79%
  7. Lymph Follicular Hypertrophy (an increase in the size of the lymph node follicles): 14 people, 29.79%
  8. Insomnia (sleeplessness): 14 people, 29.79%
  9. Constipation: 14 people, 29.79%
  10. Cough: 14 people, 29.79%

What are the existing conditions these people have? *

  1. Small Cell Lung Cancer Extensive Stage (small cell lung cancer that has spread (metastasized) to other regions of the body such as another lobe of the lung or the brain): 6 people, 12.77%
  2. White Blood Cell Count Increased: 5 people, 10.64%
  3. Breast Cancer: 3 people, 6.38%
  4. Ovarian Cancer (cancer of ovary): 3 people, 6.38%
  5. Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 2 people, 4.26%
  6. Pain: 2 people, 4.26%
  7. Depression: 2 people, 4.26%
  8. White Blood Cell Count Decreased: 2 people, 4.26%
  9. Nausea (feeling of having an urge to vomit): 2 people, 4.26%
  10. Lung Neoplasm Malignant (cancer tumour of lung): 1 person, 2.13%

* Approximation only. Some reports may have incomplete information.

Do you take Carboplatin and have Device occlusion?

- Check whether Device occlusion is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Carboplatin:

Device occlusion treatments and more:

How severe was Device occlusion and when was it recovered:

Expand to all the drugs that have ingredients of carboplatin:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Carboplatin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Device occlusion:

Browse all the conditions that are associated with Device occlusion:

Related publications that referenced our studies

How the study uses the data?

The study uses data from the FDA. It is based on carboplatin (the active ingredients of Carboplatin) and Carboplatin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.